Metropolitan Life Insurance CO Puma Biotechnology, Inc. Transaction History

Metropolitan Life Insurance CO

$252 Million
Q4 2024

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.98 - $11.6 $71 - $92	-8 Closed	0 $0
Q1 2021 Jun 26, 2023	BUY	$9.38 - $13.63 $74,026 - $107,567	7,892 New	7,892 $76.7 Million
Q1 2021 Mar 30, 2023	SELL	$9.38 - $13.63 $14,660 - $21,303	-1,563 Reduced 16.53%	7,892 $76,000
Q1 2021 May 14, 2021	SELL	$9.38 - $13.63 $88,612 - $128,762	-9,447 Reduced 99.92%	8 $77,000
Q4 2020 Jun 22, 2023	BUY	$7.78 - $12.13 $73,559 - $114,689	9,455 New	9,455 $97,000
Q3 2020 Jun 26, 2023	BUY	$9.5 - $11.14 $89,822 - $105,328	9,455 New	9,455 $95,000
Q3 2020 Mar 30, 2023	SELL	$9.5 - $11.14 $2,555 - $2,996	-269 Reduced 2.77%	9,455 $95,000
Q3 2020 Nov 13, 2020	SELL	$9.5 - $11.14 $2,555 - $2,996	-269 Reduced 2.77%	9,455 $95,000
Q2 2020 Jun 26, 2023	BUY	$7.01 - $13.24 $68,165 - $128,745	9,724 New	9,724 $101,000
Q1 2020 Jul 12, 2023	BUY	$6.28 - $14.57 $61,066 - $141,678	9,724 New	9,724 $82,000
Q1 2020 Mar 30, 2023	BUY	$6.28 - $14.57 $533 - $1,238	85 Added 0.88%	9,724 $82,000
Q1 2020 May 15, 2020	BUY	$6.28 - $14.57 $533 - $1,238	85 Added 0.88%	9,724 $82,000
Q4 2019 Jul 12, 2023	BUY	$6.5 - $10.73 $62,653 - $103,426	9,639 New	9,639 $84,000
Q4 2019 Mar 30, 2023	SELL	$6.5 - $10.73 $6,344 - $10,472	-976 Reduced 9.19%	9,639 $84,000
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $6,344 - $10,472	-976 Reduced 9.19%	9,639 $84,000
Q3 2019 Jul 12, 2023	BUY	$8.75 - $12.85 $92,881 - $136,402	10,615 New	10,615 $114,000
Q3 2019 Mar 30, 2023	BUY	$8.75 - $12.85 $11,418 - $16,769	1,305 Added 14.02%	10,615 $114,000
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $11,418 - $16,769	1,305 Added 14.02%	10,615 $114,000
Q2 2019 Jul 12, 2023	BUY	$12.3 - $35.76 $114,513 - $332,925	9,310 New	9,310 $118,000
Q1 2019 Jul 13, 2023	BUY	$20.77 - $42.37 $193,368 - $394,464	9,310 New	9,310 $361,000
Q1 2019 Mar 30, 2023	BUY	$20.77 - $42.37 $193,368 - $394,464	9,310 New	9,310 $361,000
Q1 2019 May 16, 2019	SELL	$20.77 - $42.37 $252,957 - $516,024	-12,179 Reduced 56.68%	9,310 $361,000
Q1 2019 May 15, 2019	BUY	$20.77 - $42.37 $244,899 - $499,584	11,791 Added 121.58%	21,489 $532,000
Q4 2018 Jul 13, 2023	BUY	$20.07 - $46.7 $194,638 - $452,896	9,698 New	9,698 $197,000
Q4 2018 Feb 14, 2019	BUY	$20.07 - $46.7 $154,338 - $359,123	7,690 Added 382.97%	9,698 $197,000
Q3 2018 Jul 13, 2023	BUY	$41.2 - $59.85 $384,148 - $558,041	9,324 New	9,324 $428 Million
Q3 2018 Nov 14, 2018	SELL	$41.2 - $59.85 $301,419 - $437,862	-7,316 Reduced 78.46%	2,008 $92,000
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $8,238 - $13,696	138 Added 1.5%	9,324 $0
Q4 2017 Feb 15, 2018	SELL	$93.85 - $132.45 $979,793 - $1.38 Million	-10,440 Reduced 53.19%	9,186 $908,000
Q3 2017 Nov 14, 2017	SELL	$72.0 - $119.75 $11,448 - $19,040	-159 Reduced 0.8%	19,626 $2.35 Million
Q2 2017 Aug 14, 2017	BUY	N/A	19,785	19,785 $1.73 Million

Others Institutions Holding PBYI

# of Institutions

110

Shares Held

28.3M

Call Options Held

27.9K

Put Options Held

3.4K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$12.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$12.1 Million
0.0% of portfolio
Acorn Capital Advisors, LLC New York, NY

2.45M
Shares

$8.33 Million
6.49% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$6.71 Million
0.02% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.89M
Shares

$6.44 Million
0.0% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $155M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account